Charlestrad3r

Next biotech stock to shoot up?

做多
NASDAQ:CPRX   Catalyst Pharmaceuticals, Inc.

Firdapse
Spinal Muscular Atrophy (SMA) Type 3 **** Phase 2 data due 1H 2020

Firdapse
MuSK-antibody positive myasthenia gravis (MuSK-MG) **** Phase 3 data due 1H 2020


Short Float = 13.23%

Broke out of triangle, looking for a small pullback to the cloud / support line, have a stop under suport line at 4.20 and Target at 7.50 for at possible 70% upside Gain.
Cloud turned bullish and 9 EMA crossed 21 in an upside fashion.





**'*** This is not a recommendation for entering a position, please do your own Due dillligence ******

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。